These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11570162)

  • 1. Liver fibrosis in HIV/hepatitis C coinfection: HIV protease inhibitors may be protective.
    James JS
    AIDS Treat News; 2001 Aug; (370):2-3. PubMed ID: 11570162
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C and PIs.
    Albrecht H
    AIDS Clin Care; 2001 Oct; 13(10):97. PubMed ID: 11590923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANTIRETROVIRAL THERAPY AND THE RISK OF LIVER FIBROSIS PROGRESSION IN HIV/HCV COINFECTED PATIENTS].
    Arystanbekova M; Balmasova I; Malova E; Sepiashvili R
    Georgian Med News; 2017 May; (266):58-63. PubMed ID: 28628016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
    Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
    J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV and hepatitis coinfection].
    Ingiliz P; Rockstroh JK
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S216-8. PubMed ID: 16435714
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection at the 2008 Retrovirus Conference. Liver fibrosis, hep c treatment, and the role of ART.
    Highleyman L
    Posit Aware; 2008; 19(3):32-3. PubMed ID: 18724446
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C.
    Vazquez E
    Posit Aware; 1998; 9(5):55. PubMed ID: 11365898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Managing HIV infection. 2 new aspects].
    Katlama C
    Presse Med; 1999 Nov; 28 Suppl 3():11-4. PubMed ID: 10605461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.
    Boyd A; Lasnier E; Molina JM; Lascoux-Combe C; Bonnard P; Miailhes P; Wendum D; Meynard JL; Girard PM; Lacombe K
    Antivir Ther; 2010; 15(7):963-74. PubMed ID: 21041911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction?
    Verma S
    J Antimicrob Chemother; 2006 Sep; 58(3):496-501. PubMed ID: 16854955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infections. Hepatitis C virus--some background information.
    TreatmentUpdate; 2008; 20(3):5-8. PubMed ID: 18661654
    [No Abstract]   [Full Text] [Related]  

  • 14. NNRTI hepatotoxicity: efavirenz versus nevirapine.
    Pulido F; Torralba M
    J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215
    [No Abstract]   [Full Text] [Related]  

  • 15. Saquinavir therapy in patients with the advanced HIV infection and liver cirrhosis.
    Tachikawa N; Yoshizawa S; Kikuchi Y; Yasuoka A; Oka S
    Jpn J Infect Dis; 1999 Aug; 52(4):177-8. PubMed ID: 10592905
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV Protease Inhibitors Associated with Increased HCV Viral Load in Coinfected Patients.
    Labarga P
    AIDS Rev; 2015; 17(3):186. PubMed ID: 26450806
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV.
    Yamamoto Y; Yasuoka A; Tachikawa N; Teruya K; Genka I; Yamaguchi M; Yasuoka C; Kikuchi Y; Aoki M; Oka S
    Jpn J Infect Dis; 1999 Dec; 52(6):248-9. PubMed ID: 10738365
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver fibrosis and antiretroviral therapy.
    Ghosn J
    Clin Infect Dis; 2006 Jan; 42(2):271-2. PubMed ID: 16355340
    [No Abstract]   [Full Text] [Related]  

  • 19. Focus on hepatitis. HIV/HCV coinfection and ART.
    Carter M
    IAPAC Mon; 2006 May; 12(5):157. PubMed ID: 17249142
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coinfection of HCV and HIV].
    Yotsuyanagi H; Koike K
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():300-5. PubMed ID: 26845949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.